Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-041388)

Filing Details

Accession Number:: 0001181431-10-041388
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-11 13:00:00
Reporting Period:: 2010-08-10

Filing Date:: 2010-08-11
Accepted Time:: 2010-08-11 13:47:32
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1385830	Neurogesx Inc	NGSX	Pharmaceutical Preparations (2834)	943307935

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1293633	S Bradford Goodwin	C/O Neurogesx, Inc. 2215 Bridgepointe Parkway, Suite 200 San Mateo CA 94404		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-08-10	5,000	$6.03	15,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The purchase price reported in column 4 of Table I represents the weighted average purchase price of the shares purchased ranging from $6.000 to $6.070 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.